Source link : https://www.newshealth.biz/health-news/three-cancer-medicines-green-lighted-in-europe/
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended that marketing authorizations be approved for three new cancer drugs: Datroway (datopotamab deruxtecan) to treat advanced breast cancer, Tivdak (tisotumab vedotin) for recurrent or metastatic cervical cancer, and Dyrupeg (pegfilgrastim) for neutropenia following chemotherapy. Datroway for Breast Cancer The […]
Author : News Health
Publish date : 2025-01-31 17:05:14
Copyright for syndicated content belongs to the linked Source.